Inhibition of in vitro hematopoiesis by hepatitis A virus.
Inoculation of human bone marrow with hepatitis A virus (HAV) resulted in a dose- and duration-of-incubation-dependent suppression of hematopoietic progenitor (CFU-GM, BFU-E, CFU-Mix) growth in vitro. Monocytic progenitors appeared to be least affected. While HAV inactivation by heat or beta-propiolactone and neutralization by specific antibodies completely abrogated hematopoietic inhibition, depletion of adherent bone marrow cells, and enrichment of progenitors did not alter the pattern of suppression, which also seemed to be independent of HuIFN-alpha, -beta, -gamma, and TNF. These findings support the concept that direct infection of progenitor cells by HAV may be responsible for hematologic changes commonly seen during early phases of infectious hepatitis and possibly for some cases of bone marrow failure.
D000328:Adult; D000914:Antibodies, Viral / Q000276:immunology; D001854:Bone Marrow Cells; D002478:Cells, Cultured; D006410:Hematopoiesis; D006412:Hematopoietic Stem Cells / Q000166:cytology*; D006507:Hepatovirus / Q000187:drug effects / Q000276:immunology / Q000502:physiology*; D006358:Hot Temperature; D006801:Humans; D007372:Interferons / Q000494:pharmacology; D011420:Propiolactone / Q000494:pharmacology; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology
D000914:Antibodies, Viral; D014409:Tumor Necrosis Factor-alpha; D011420:Propiolactone; D007372:Interferons